Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis
Titel:
Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis
Auteur:
Labidi-Galy, S.I. Rodrigues, M. Sandoval, J.L. Kurtz, J.E. Heitz, F. Mosconi, A.M. Romero, I. Denison, U. Nagao, S. Vergote, I. Parma, G. Nøttrup, T.J. Rouleau, E. Garnier, G. El-Balat, A. Zamagni, C. Martín-Lorente, C. Pujade-Lauraine, E. Fiévet, A. Ray-Coquard, I.L.